Chauhan Rajeev, Otaal Parminder S
Department of Cardiology, Post Graduate Institute of Medicine and Research, Chandigarh, IND.
Department of Cardiology/Interventional Cardiology, Post Graduate Institute of Medical Education and Research, Chandigarh, IND.
Cureus. 2023 Jan 25;15(1):e34188. doi: 10.7759/cureus.34188. eCollection 2023 Jan.
Percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) with high-grade thrombus is a high-risk intervention associated with poor clinical outcomes. Circulatory support with an intra-aortic balloon pump (IABP) during PCI may potentially improve coronary hemodynamics and clinical outcomes in such patients. As existing data on this situation are sparse, we did an observational study to determine short-term outcomes of PCI with IABP support in STEMI patients with high thrombus burden.
To determine whether IABP has a potential role in improving outcomes in patients with STEMI with high thrombus burden who are undergoing PCI.
Thirty consecutive patients of STEMI with high thrombus burden undergoing PCI with IABP assistance were included. Ninety-three percent of patients had a cardiogenic shock. Clinical and angiographic outcomes assessed include a change in left ventricular ejection fraction (LVEF), 30-day mortality, and assessment of TIMI (thrombolysis in myocardial infarction) flow, TIMI frame count, and TIMI myocardial perfusion grade in the culprit vessel. IABP was initiated before coronary angiography in 36.6% (n=11), between angiography and PCI in 30% (n=9), and after PCI in 33.3% (n=10) of patients. During the 30-day follow-up period, 50% (n=15) of patients died. 86.6% (n=13) of survivors had pre-PCI IABP initiation compared to only 46.6% (n=7) among those who died (p=0.020). With pre-PCI IABP initiation (n=20), 30-day mortality was 35% (n=7) compared to 80% (n=8) with post-PCI IABP initiation (n=10) (p=0.020).
IABP initiation before PCI in STEMI complicated by cardiogenic shock and high angiographic thrombus burden can decrease mortality without any effect on angiographic parameters.
在伴有高度血栓的ST段抬高型心肌梗死(STEMI)患者中进行经皮冠状动脉介入治疗(PCI)是一种高风险的干预措施,临床预后较差。PCI期间使用主动脉内球囊反搏(IABP)进行循环支持可能会改善此类患者的冠状动脉血流动力学和临床预后。由于关于这种情况的现有数据较少,我们进行了一项观察性研究,以确定在伴有高血栓负荷的STEMI患者中接受IABP支持的PCI的短期预后。
确定IABP在改善接受PCI的伴有高血栓负荷的STEMI患者的预后方面是否具有潜在作用。
纳入30例连续接受IABP辅助PCI治疗的伴有高血栓负荷的STEMI患者。93%的患者发生心源性休克。评估的临床和血管造影结果包括左心室射血分数(LVEF)的变化、30天死亡率,以及对罪犯血管的心肌梗死溶栓(TIMI)血流、TIMI帧数和TIMI心肌灌注分级的评估。36.6%(n=11)的患者在冠状动脉造影前开始使用IABP,30%(n=9)的患者在造影和PCI之间开始使用,33.3%(n=10)的患者在PCI后开始使用。在30天的随访期内,50%(n=15)的患者死亡。存活患者中有86.6%(n=13)在PCI前开始使用IABP,而死亡患者中只有46.6%(n=7)(p=0.020)。在PCI前开始使用IABP(n=20)的患者中,30天死亡率为35%(n=7),而在PCI后开始使用IABP(n=10)的患者中为80%(n=8)(p=0.020)。
在并发心源性休克和血管造影显示高血栓负荷的STEMI患者中,PCI前开始使用IABP可降低死亡率,且对血管造影参数无影响。